SCHEMBL18023657

SCHEMBL18023657

CCOC(CCNC(=O)c1ccc(CC)cc1)OCC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 1/20 0.50
▸ TAS1R3 Q7RTX0 1/20 0.50
▸ TAS1R1 Q7RTX1 1/20 0.50
▸ MAPK1 P28482 2/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ NLRP1 Q9C000 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TPSAB1 Q15661 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17978853 0.89 NPC1 (0.48) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12997229 0.85 LMNA (0.55) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12997232 0.84 HDAC3 (0.50) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL29798859 0.83 NPC1 (0.58) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13360502 0.81 SMN1; SMN2 (0.65) PLK1TAS1R3TAS1R1ALDH1A1TDP1
SCHEMBL18259868 0.80 POLB (0.61) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13814872 0.79 PLK1 (0.53) PLK1TAS1R3TAS1R1MAPK1ALDH1A1
SCHEMBL18259815 0.78 NPC1 (0.52) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6360077 0.77 PLK1 (0.63) PLK1TAS1R3TAS1R1MAPK1ALDH1A1
SCHEMBL5948073 0.77 EPHX2 (0.74) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016128456-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2016-08-18 — — WO disclosed
Send feedback